Several subgroups should be thus considered with a special interest on older patients, on patients with cardiac comorbidities, with acute ischemic event, acute brain injury or with cancer for whom a Hb threshold of 8–9 g/dL may be more appropriate. The gene discussed is GSTM1; the disease is cancer.